Finance Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHAMay 19, 20250 Gilead Sciences, Inc. (NASDAQ:GILD) plans to current over 20 analysis abstracts—spanning each Gilead and its cell remedy unit Kite—at two…
Health Incoming ASCO president buoyed by cancer advancesJune 7, 20230 CHICAGO — As a busy weekend on the American Society of Scientific Oncology annual assembly wound down, Lynn Schuchter accepted…
Health ASCO showcased payoff for new cancer medicines: longer livesJune 7, 20230 CHICAGO — Properly, that’s a wrap. The largest assembly in most cancers analysis — and, actually, one of many greatest…
